Table 1

Antiviral activity of BPR1P0034.

Concentration (μM)


BPR1P0034

Amantadine

Zanamivir



IC50

CC50c

IC50

IC50


Cytotoxic effect

MDCK

6.75 ± 0.08

Influenza virus

A/WSN/33 (H1N1)b

0.21 ± 0.07

> 25

0.06 ± 0.02

A/Udorn/72 (H3N2)a

2.11 ± 0.41

0.98 ± 0.15

0.67 ± 0.23

A/TW/83/05 (H3N2)a

1.38 ± 0.08

> 25

0.92 ± 0.03

A/TW/785/05 (H1N1)a

0.92 ± 0.11

0.38 ± 0.24

1.06 ± 0.98

B/TW/710/05b

8.11 ± 3.98

> 25

0.03 ± 0.02

B/TW/70325/05b

1.94 ± 0.72

> 25

0.02 ± 0.01

B/TW/99/07b

8.90 ± 4.16

> 25

0.10 ± 0.01

Enterovirus 71b

TW/1743/98

> 40

> 20

--

--

TW/4643/98

> 20

> 20

--

--

Echovirus 9b

> 20

> 20

--

--


MDCK cells or Vero cells were infected with influenza virus and EV71, respectively, and incubated with different concentrations of BPR1P0034.

IC50was determined with a plaque reduction assaya or a neutralization assayb

cCC50 was determined with an MTT assay

--, not determined

The values are means ± SD of 2--3 independent experiments.

Shih et al. Journal of Biomedical Science 2010 17:13   doi:10.1186/1423-0127-17-13

Open Data